Principal Investigators
Drs. Robin Goland and Mary Pat Gallagher

Purpose of Study
Randomized, controlled trial an oral formulation of insulin in relatives of people with type 1 diabetes. Subjects have normal glucose tolerance and autoantibodies against insulin and islet cells demonstrating higher risk for development of type 1 diabetes.

Who is Eligible for This Study?

Age: Between 3 and 45 years old.

Type of Diabetes: Non-diabetic relatives of people with type 1 diabetes

Time Commitment
Study visits take place over a 2 year period.

Reimbursement
Patients receive diabetes medications and glucose testing supplies at no cost during the study. Participants will have the opportunity to continue taking inhaled insulin.

Contact
Please contact Ellen Greenberg, at 212-851-5425 or by email emg25@columbia.edu